Suppr超能文献

胰腺浸润性导管内乳头状黏液性癌:生存预测因素和淋巴结比率的作用。

Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.

机构信息

Department of Surgery, University of Verona, Verona, Italy.

出版信息

Ann Surg. 2010 Mar;251(3):477-82. doi: 10.1097/SLA.0b013e3181cf9155.

Abstract

INTRODUCTION

Intraductal papillary mucinous neoplasms (IPMNs) are being increasingly recognized, and often harbor cancer. Lymph node metastases are an important prognostic factor for patients with invasive intraductal papillary carcinoma (I-IPMC), but the role of lymph node ratio (LNR) in predicting survival after surgery for I-IPMC is unknown.

METHODS

The combined databases from the Surgical Department of Massachusetts General Hospital of Boston and the University of Verona were queried. We retrospectively reviewed clinical and pathologic data of all patients with resected, pathologically confirmed, I-IPMC between 1990 and 2007. Univariate and multivariate analysis were performed.

RESULTS

I-IPMCs were diagnosed in 104 patients (55 males and 49 females), median age was 69 years. Recurrent disease was identified in 49 patients (47.1%) and the median 5-year disease specific survival (DSS) was 60.1%. The median number of resected/evaluated nodes was 15 (range, 5-60). There were 60 (57.7%) patients who had negative lymph nodes (N0), whereas 44 (42.3%) had lymph node metastases (N1). Patients with lymph node metastases had a shorter 5-year DSS (28.9%) compared with patients with negative lymph nodes (80.3%; P < 0.05) As the LNR increased, 5-year DSS decreased (LNR = 0, 86.5%; LNR >0 to 0.2, 34.4%; LNR >0.2, 11.1%; P < 0.05). On multivariate analysis, LNR, the presence of a family history of pancreatic cancer and a preoperative value of Ca 19.9 > 37 U/L were significant predictors of survival (P < 0.05).

CONCLUSIONS

Lymph node ratio is a strong predictor of survival after resection for invasive intraductal papillary mucinous carcinoma.

摘要

简介

导管内乳头状黏液性肿瘤(IPMNs)的发病率越来越高,且常伴有癌症。淋巴结转移是浸润性导管内乳头状癌(I-IPMC)患者的一个重要预后因素,但淋巴结比率(LNR)在预测 I-IPMC 手术后生存情况中的作用尚不清楚。

方法

我们检索了波士顿马萨诸塞州综合医院外科部门和维罗纳大学的联合数据库。回顾性分析了 1990 年至 2007 年间经手术切除并经病理证实的 I-IPMC 患者的临床和病理资料。进行了单因素和多因素分析。

结果

诊断为 I-IPMC 的患者有 104 例(55 例男性和 49 例女性),中位年龄为 69 岁。49 例(47.1%)患者出现复发病例,中位 5 年疾病特异性生存率(DSS)为 60.1%。切除/评估的淋巴结中位数为 15 个(范围为 5-60 个)。60 例(57.7%)患者为淋巴结阴性(N0),44 例(42.3%)为淋巴结转移(N1)。淋巴结转移患者的 5 年 DSS 明显较短(28.9%),而淋巴结阴性患者的 5 年 DSS 较长(80.3%;P < 0.05)。随着 LNR 的增加,5 年 DSS 降低(LNR = 0,86.5%;LNR >0 至 0.2,34.4%;LNR >0.2,11.1%;P < 0.05)。多因素分析显示,LNR、家族性胰腺癌病史和术前 CA 19.9 值>37 U/L 是生存的显著预测因素(P < 0.05)。

结论

淋巴结比率是预测浸润性导管内乳头状黏液性癌切除后生存情况的一个强有力的预测因子。

相似文献

3
Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9. doi: 10.1097/01.sla.0000128306.90650.aa.
5
Evaluation of preoperative prognostic factors in patients with resectable invasive intraductal papillary mucinous carcinoma.
Surgery. 2020 Dec;168(6):994-1002. doi: 10.1016/j.surg.2020.01.014. Epub 2020 Mar 3.
7
Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):839-44. doi: 10.1016/j.ijrobp.2009.02.071. Epub 2009 Aug 3.
10

引用本文的文献

2
Is chemotherapy beneficial? A retrospective study of chemotherapy in patients with invasive intraductal papillary-mucinous carcinoma.
Heliyon. 2024 Sep 26;10(19):e38430. doi: 10.1016/j.heliyon.2024.e38430. eCollection 2024 Oct 15.
3
Evaluation of AJCC Nodal Staging for Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Ductal Adenocarcinoma.
Ann Surg Oncol. 2024 Dec;31(13):8712-8720. doi: 10.1245/s10434-024-16055-5. Epub 2024 Sep 16.
6
CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway.
Cancer Cell Int. 2022 Nov 7;22(1):340. doi: 10.1186/s12935-022-02768-8.
10
Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms.
Front Endocrinol (Lausanne). 2021 Mar 5;12:613755. doi: 10.3389/fendo.2021.613755. eCollection 2021.

本文引用的文献

1
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Ann Surg Oncol. 2008 Nov;15(11):3178-86. doi: 10.1245/s10434-008-0099-4. Epub 2008 Aug 20.
2
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
Arch Surg. 2008 Jul;143(7):639-46; discussion 646. doi: 10.1001/archsurg.143.7.639.
5
Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management.
J Gastrointest Surg. 2008 Apr;12(4):645-50. doi: 10.1007/s11605-007-0447-x. Epub 2007 Dec 19.
8
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection.
Gastroenterology. 2007 Jul;133(1):72-9; quiz 309-10. doi: 10.1053/j.gastro.2007.05.010. Epub 2007 May 10.
9
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
Surgery. 2007 May;141(5):610-8. doi: 10.1016/j.surg.2006.12.013. Epub 2007 Mar 23.
10
Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas.
J Gastrointest Surg. 2007 Mar;11(3):338-44. doi: 10.1007/s11605-006-0069-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验